Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
07/1998
07/01/1998CN1186517A Altered polypeptides with increased half-life
07/01/1998CN1186501A Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
07/01/1998CN1186495A Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
07/01/1998CN1186487A Acetamide derivatives, process for producing the same, and medicinal composition containing the same
07/01/1998CN1186434A Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
07/01/1998CN1185968A Superfined American ginseng capsule and preparation thereof
07/01/1998CN1038939C Preparation of peptide compounds
07/01/1998CN1038932C Stereoselective preparation of substitued piperidines
06/1998
06/30/1998US5773581 Acid stable substance dervived from naturally occuring granulocyte colony stimulating factor
06/30/1998US5773570 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
06/30/1998US5773470 Treating rheumatic diseases, autoimmune diseases and rejection reactions due to organ transplanting
06/30/1998US5773450 Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
06/30/1998US5773010 Low molecular weight allergen obtained from Dermatophagoides farinae
06/30/1998US5773006 Lipsome containing IL-2
06/30/1998US5773002 Miticides
06/30/1998US5772995 Compositions and methods for enhanced tumor cell immunity in vivo
06/30/1998US5772981 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
06/25/1998WO1998027208A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
06/25/1998WO1998027098A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE
06/25/1998WO1998026790A1 Mycobacterium vaccae for down-regulation of the th2 activity of the immune system
06/25/1998WO1998022100A3 New use for 1,3-propanediol derivatives
06/25/1998WO1998019649A3 Methods and compositions for inhibition of angiogenesis
06/25/1998WO1998003552A3 A multivalent major histocompatibility complex peptide fusion protein for modulating specific t cell function
06/25/1998WO1998002151A3 Chemokine receptor antagonists and methods of use therefor
06/24/1998EP0849256A1 Amide compounds and use of the same
06/24/1998EP0848717A1 Process for the preparation of imidazolyl macrolide immunosuppressants
06/24/1998EP0642333B1 Method and composition for the treatment of disorders involving immunological dysfunction
06/24/1998CN1185740A Chlamydia vaccines
06/23/1998US5770772 4-formylamino-2,3,5-trimethyl-1-(2-methyl-2-propenyloxy) -benzene; arteriosclerosis, brain and cardiovascular disorders
06/23/1998US5770735 Neurokinin receptor antagonists
06/23/1998US5770618 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
06/23/1998US5770607 Aqueous liquid composition for external use
06/23/1998US5770577 BDNF and NT-3 polypeptides selectively linked to polyethylene glycol
06/23/1998US5770401 Such as cutaneous, ocular, nasal and bronchial allergic disease; interleukins and tumor necrosis factor receptors; competitive binding
06/23/1998US5770396 Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
06/23/1998US5770202 Cloning and sequencing of allergens of dermatophagoides (house dust mite)
06/23/1998US5770197 Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
06/23/1998US5770196 Modified antibody variable domains and therapeutic uses thereof
06/23/1998CA2176506C Substituted oxindoles
06/23/1998CA2119636C Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives
06/23/1998CA2033531C Azaoxindole derivatives
06/18/1998WO1998026068A1 Human apoptosis-related calcium-binding protein
06/18/1998WO1998026061A2 Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
06/18/1998WO1998026049A1 Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine
06/18/1998WO1998025971A1 Monovalent antibody fragments
06/18/1998WO1998025951A1 Inhibitors of peptide binding to mhc class ii proteins
06/18/1998WO1998025919A1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them
06/18/1998WO1998025875A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
06/18/1998WO1998025574A2 Stimulation of an immune response to differentiation antigen stimulated by altered antigen
06/18/1998WO1998025469A1 The use of cd4-binding small molecules to inhibit immune responses
06/18/1998WO1998018477A3 Pharmaceutical compositions containing lamivudine and zidovudine
06/18/1998WO1998008956A3 Use of a mutated macrolide binding protein for the prevention of gvhd
06/18/1998WO1998005361A3 Long-acting drugs and pharmaceutical compositions comprising them
06/18/1998WO1998003194A3 Substance p treatment for immunostimulation
06/18/1998CA2707726A1 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
06/18/1998CA2274900A1 Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine
06/18/1998CA2274838A1 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
06/18/1998CA2274739A1 Human apoptosis-related calcium-binding protein
06/18/1998CA2274604A1 The use of cd4-binding small molecules to inhibit immune responses
06/17/1998EP0848063A2 Nucleic acid constructs containing hybrid promotors for use in gene therapy
06/17/1998EP0848061A2 Self-enhancing, pharmacologically controllable expression systems
06/17/1998EP0847443A1 Crystalline zap family proteins
06/17/1998EP0847280A2 Compositions and their uses
06/17/1998CN1185110A Synergistic combination of zidovudine
06/16/1998US5767241 Soluble form of GMP-140
06/16/1998US5767122 Enantiomerically pure β-d-dioxolane nucleosides
06/16/1998US5767120 Antiinflammatory agents, antiallergens; treatment for septic shock
06/16/1998US5767118 4-Heterocyclic peperidines promote release of growth hormone
06/16/1998US5767093 Glycoside antigen, inhibiting rejection of transplanted organs
06/16/1998US5767087 Administering purified glutamic acid-tryptophan dipeptide toincrease number of lymphocytes or karyocytes in non-human animal
06/16/1998US5767075 Inhibiting protein interactions
06/16/1998US5767069 Cyclosporins
06/16/1998US5767065 Use of interleukin-4 receptors to inhibit biological responses mediated by interleukin-4
06/16/1998US5766947 Useful in the diagnosis and therapy of a variety of immune-related diseases
06/16/1998US5766886 Modified antibody variable domains
06/16/1998US5766845 Immunoreactive polypeptide compositions
06/16/1998US5766629 Nonionic surfactant, alkanol
06/16/1998US5766624 Liposomal defensins
06/16/1998US5766594 Dna sequences encoding a polypeptide reactive with nti-mycoplasma gallisepticum chicken sera; expressed by a genetically engineered cell
06/16/1998US5766570 Lymphocyte activation antigens and antibodies thereto
06/16/1998CA2165779C Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
06/16/1998CA2132457C Fluorosugar derivatives of macrolides
06/16/1998CA2040374C Process for enhancing the resistance of aquatic animals to disease
06/11/1998WO1998024927A1 Compositions and methods for administering pneumococcal dna
06/11/1998WO1998024916A1 Novel calpaines, production and use thereof
06/11/1998WO1998024910A2 Mutants of streptococcal toxin c and methods of use
06/11/1998WO1998024908A1 Human chemokine beta-13
06/11/1998WO1998024906A2 Isolated mammalian monocyte cell genes; related reagents
06/11/1998WO1998024905A2 Secreted proteins and polynucleotides encoding them
06/11/1998WO1998024902A1 Adaptor protein frs2 and related products and methods
06/11/1998WO1998024805A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/11/1998WO1998024794A1 PHENYL GLYOXAMIDES AS sPLA2 INHIBITORS
06/11/1998WO1998024782A2 Substituted pyrimidine compounds and their use
06/11/1998WO1998024780A2 Substituted pyrimidinone and pyridinone compounds and their use
06/11/1998WO1998024763A2 Immunotherapeutic imides/amides as pde iv and tnf inhibitors
06/11/1998WO1998024762A1 Vitamin d3 derivatives
06/11/1998WO1998024476A1 Method to prevent transplant rejection
06/11/1998WO1998024450A1 Novel formulation
06/11/1998WO1998024437A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors
06/11/1998WO1998024429A1 Synthetic techniques and intermediates for polyhydroxy, dienyllactones and mimics thereof
1 ... 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 ... 1172